{"name":"Ferrosan AS","slug":"ferrosan-as","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"Ginger-Avocado-Soya","genericName":"Ginger-Avocado-Soya","slug":"ginger-avocado-soya","indication":"General nutritional support and wellness (marketed indication not formally defined)","status":"marketed"},{"name":"Glucosamine sulphate","genericName":"Glucosamine sulphate","slug":"glucosamine-sulphate","indication":"Other","status":"marketed"}]},{"name":"Pain","slug":"pain","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Ginger-ibuprofen","genericName":"Ginger-ibuprofen","slug":"ginger-ibuprofen","indication":"Pain and inflammation (general indication for marketed NSAID-ginger combination)","status":"marketed"}]}],"pipeline":[{"name":"Ginger-Avocado-Soya","genericName":"Ginger-Avocado-Soya","slug":"ginger-avocado-soya","phase":"marketed","mechanism":"This is a botanical dietary supplement combining ginger, avocado, and soya that may provide nutritional support and anti-inflammatory benefits through naturally occurring phytochemicals.","indications":["General nutritional support and wellness (marketed indication not formally defined)"],"catalyst":""},{"name":"Ginger-ibuprofen","genericName":"Ginger-ibuprofen","slug":"ginger-ibuprofen","phase":"marketed","mechanism":"Ibuprofen inhibits cyclooxygenase (COX) enzymes to reduce prostaglandin synthesis and inflammation, while ginger provides additional anti-inflammatory and analgesic effects through multiple pathways.","indications":["Pain and inflammation (general indication for marketed NSAID-ginger combination)"],"catalyst":""},{"name":"Glucosamine sulphate","genericName":"Glucosamine sulphate","slug":"glucosamine-sulphate","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMib0FVX3lxTFBFUER6emRhZkMzSC02NDNfOTg5YkU4cFdPcXlPU2VXX1E3OUFnTEZpcWxMdEFmYkdFRjkybC1SVTI1ZGJoQmRSMzBZNzYtMjN6UHFPYjI4dzY1WmI2cDBVaGdrcGV5U0RqeEpxemplMA?oc=5","date":"2025-09-30","type":"pipeline","source":"medwatch.com","summary":"Layoffs rolling in: \"The pharmaceutical industry is entering one of the toughest cycles in decades\" - medwatch.com","headline":"Layoffs rolling in: \"The pharmaceutical industry is entering one of the toughest cycles in decades\"","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMib0FVX3lxTE1waFNJNi1uaVVHZWlONFhUNE5pSHVURHhxWU1ocG5Hc3BpREl4ZVlKV1VLSVNJRnE4Sk1mdzR3SU9mdUJGa1hQZUFUSDZXVEF2T3h6VGtNODB6MFY3VThacmUyZmhkMWRKMUh1RDFNbw?oc=5","date":"2021-03-01","type":"pipeline","source":"medwatch.com","summary":"Novo Nordisk Pharmatech to open new sales office in US - medwatch.com","headline":"Novo Nordisk Pharmatech to open new sales office in US","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2019-02-22","type":"pipeline","source":"Romania Insider","summary":"Pfizer to expand on production segment in Romania through acquisition of Ferrosan - Romania Insider","headline":"Pfizer to expand on production segment in Romania through acquisition of Ferrosan","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxNUjVHdnNydUZHdEhkVWpfQXgyZ1NQT3p6UUdKWWp5SzhYcEdhSFlwRmU5RW5lQnQtZE9hZS1WcWQtLXdJNmNCR3BNamFWM0RpYTZieklXYlA0azJkNEpzUF8xZC1FR0dEY3I3bWlYVDhLUEZZdmwyeHRMNHdjV2hQYm11VDdtazZNdVhGa0FEa3lkeXpwZnF1MVcxTW5WM3dWbERHWE1FQldwTUFhLTZCY05OUnZoblc1QWpiMHRPNFVDTzdq?oc=5","date":"2017-07-07","type":"deal","source":"Cision News","summary":"Impilo acquires Ferrosan Medical Devices, a global leading manufacturer of hemostats - Cision News","headline":"Impilo acquires Ferrosan Medical Devices, a global leading manufacturer of hemostats","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiY0FVX3lxTFBINy0waVZjTkFRcFprbVRlY2VqMDEwcGFZTmhkbHB5bWIwb3o1LTkyN0JYaURDSlp1aDg1U1BoT25Ja2NRYnFFcURheU0wRkRjdUprdzk4VFFxU0NMTFIzcm5tbw?oc=5","date":"2009-10-22","type":"trial","source":"Clinical Trials Arena","summary":"Paxil – SSRI for the Treatment of Major Depressive Disorders - Clinical Trials Arena","headline":"Paxil – SSRI for the Treatment of Major Depressive Disorders","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiUEFVX3lxTE8zRHo3VC1UTl9hLVRDcXQzZkM3dTRaSHppUUcxZ2ZvcVFaV3ZPcjVXYzJFazZPYkN0Q211UnR2RXRBVDA4X2YxejdkSGxNS215?oc=5","date":"2008-01-22","type":"pipeline","source":"FoodChain Magazine","summary":"Ferrosan - FoodChain Magazine","headline":"Ferrosan","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZkFVX3lxTE5Jd2JBM1QyWWNRZ3Q5dXFvVGRDLXBLcXR4aHdmUF9RRmZUOGw1SzJJUHRiamZ6NkVTMUJsU1BQcTVRY19mMlFuRVJnLUZaVnNsXy01bmJZaUF3S0xPZGNnaEZUek1wUdIBZkFVX3lxTE9vS3BPbTlybDVGR2ljZ210amhtbFB6OUZjOVZqWnJnNFV2Wnd1SVNIeGxHdzNxeS1LMWw0SDRNcEdxc1hCS1dPbmxGSE5GZ2I3ODN4cURlUzBwOWd1Q2hXVnEwbEo1UQ?oc=5","date":"2007-05-01","type":"pipeline","source":"South China Morning Post","summary":"Brand story: Imedeen - South China Morning Post","headline":"Brand story: Imedeen","sentiment":"neutral"}],"patents":[],"drugCount":3,"phaseCounts":{"marketed":3},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}